A prominent Democratic U.S. senator is slamming pharmaceutical companies for opposing marijuana legalization.

"To them it's competition for chronic pain, and that's outrageous because we don't have the crisis in people who take marijuana for chronic pain having overdose issues," Sen. Kirsten Gillibrand of New York said. "It's not the same thing. It's not as highly addictive as opioids are."

"On the federal level, we really need to say it is a legal drug you can access if you need it," she said.

Click here to read the complete article

Tom Angell ~ Forbes.com

Recent News Articles

Monday May 20

State Treasurers Group Endorses Marijuana Banking Legislation - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

A group representing state treasurers and finance officials is formally calling on Congress to pass…

740 hits

Monday May 20

At Vt. Cannabis And Hemp Convention, Some Businesses Having #FOMO - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

The Vermont Cannabis and Hemp Convention took place at the Champlain Valley Expo this weekend.

778 hits

Monday May 20

Arizona Farmers Can Begin Growing Hemp in June - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

Arizona farmers can begin planting hemp in early June. Hemp industry applications are due by…

1639 hits

Monday May 20

Cannabis-brewed Beer Prepares to Enter the New Canadian Market - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

The world’s first beer brewed from cannabis will be ready when Canada legalizes cannabis beverages…

1253 hits

Tuesday May 21

Poll: Most of Illinois says marijuana should be legal - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

A new poll by Global Strategy Group on behalf of Think Big Illinois, says a…

923 hits